中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
18期
119-121
,共3页
盐酸丙卡特罗%盐酸氨溴索%肺炎
鹽痠丙卡特囉%鹽痠氨溴索%肺炎
염산병잡특라%염산안추색%폐염
Procaterol Hydrochloride%Ambroxol Hydrochloride%Pneumonia
目的 探讨盐酸氨溴索与盐酸丙卡特罗对小儿肺炎的临床治疗效果分析.方法选择我院2012年1月~2014年2月收治的92例小儿肺炎患儿为研究对象,随机分为对照组46例,观察组46例,对照组实施基础治疗,观察组在对照组基础上加用盐酸丙卡特罗及盐酸氨溴索治疗,对两组患儿临床治疗效果进行分析.结果 观察组治疗总有效率为95.65%,对照组为76.09%,观察组显著较对照组高(P<0.05);对照组用药后不良反应发生率为10.87%,观察组为8.70%,两组患儿用药不良反应发生率无明显差异(P>0.05).结论 小儿肺炎采取盐酸丙卡特罗、盐酸氨溴索联合治疗方案,可取得良好的治疗效果,具有较高安全性.
目的 探討鹽痠氨溴索與鹽痠丙卡特囉對小兒肺炎的臨床治療效果分析.方法選擇我院2012年1月~2014年2月收治的92例小兒肺炎患兒為研究對象,隨機分為對照組46例,觀察組46例,對照組實施基礎治療,觀察組在對照組基礎上加用鹽痠丙卡特囉及鹽痠氨溴索治療,對兩組患兒臨床治療效果進行分析.結果 觀察組治療總有效率為95.65%,對照組為76.09%,觀察組顯著較對照組高(P<0.05);對照組用藥後不良反應髮生率為10.87%,觀察組為8.70%,兩組患兒用藥不良反應髮生率無明顯差異(P>0.05).結論 小兒肺炎採取鹽痠丙卡特囉、鹽痠氨溴索聯閤治療方案,可取得良好的治療效果,具有較高安全性.
목적 탐토염산안추색여염산병잡특라대소인폐염적림상치료효과분석.방법선택아원2012년1월~2014년2월수치적92례소인폐염환인위연구대상,수궤분위대조조46례,관찰조46례,대조조실시기출치료,관찰조재대조조기출상가용염산병잡특라급염산안추색치료,대량조환인림상치료효과진행분석.결과 관찰조치료총유효솔위95.65%,대조조위76.09%,관찰조현저교대조조고(P<0.05);대조조용약후불량반응발생솔위10.87%,관찰조위8.70%,량조환인용약불량반응발생솔무명현차이(P>0.05).결론 소인폐염채취염산병잡특라、염산안추색연합치료방안,가취득량호적치료효과,구유교고안전성.
Objective This article aims to study the contrastive analysis of clinical therapeutic effect analysis between Procaterol Hydrochloride uinte Ambroxol Hydrochloride and Conventional treatment using in the treatment of infantile pneumoniaMethods Treated 92 cases of children between January 2012 and February 2012 in our hospital with infantile pneumonia as the research object, 46 cases in control group and 46 cases in observation group;the control group implement the foundation treatment and the observation group on the basis of foundation treatment using Procaterol Hydrochloride uinte Ambroxol Hydrochloride extra. Analysing the clinical curative effect of the two groups .Results The observation group of the total effective treatment rate was 95.56%, control group was 76.09%, the observation group was significantly better than the control group (P<0.05); Control group after the incidence of adverse reactions was 10.87%, the observation group was 8.70%, no obvious differences was found between two groups of children with drug adverse reaction rate (P>0.05).Conclusion The infantile pneumonia patients treated with Procaterol Hydrochloride unite Ambroxol Hydrochloride gets a good curative effect and a high safety,so it is worth of clinical promotion.